Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› LAT2
LAT2
(1 companies · 2 programs)
Companies with an active program directed at LAT2.
Telix Pharmaceuticals Ltd
TLX
Pixclara
— Glioma
Approved
Pixclara
— Brain Metastases
Phase 1